GMAB
Ticker
Genmab A/S
GMAB · Healthcare · Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases…Genmab A/S (GMAB), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 member of Congress: 1 purchase and 0 sales, 1 filed past the deadline. Filers took a median of 113 days from execution to disclosure, and the most recent trade was executed Mar 30 and filed Jul 21. The most active filer was Alan Armstrong with 1 filing. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
1
1 buy · 0 sells · 1 late
Traders, ttm
1
1 congress
Volume, ttmiDollar value disclosed in the window
$8K
estimated for Congress, as filed for insiders
Median delay
113d
execution to disclosure
Last traded
Mar 30
Filed Jul 21
ADViAverage daily dollar volume
$57.3M
market data
Share price · 12M
$32.96 (+13.4%)
Adjusted for splits and dividends.
Volume by month
Buys $16K
Sells $8K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
JGRecent filings
Alan ArmstrongPURCHASE
Senator
$8K$1K–15K bracket
Exec Mar 30
Filed Jul 21 † Josh GottheimerPURCHASE Representative (Joint) $8K
$1K–15K bracket
Exec Jan 16 2025
Filed Feb 10 2025 Josh GottheimerSALE Representative (Joint) $8K
$1K–15K bracket
Exec Dec 16 2024
Filed Jan 14 2025